2m 2m 2m 2m 2m 2m 2m
AARDVARK THERA (AARD)
NASDAQ
$4.22-$0.02 (-0.35%)
Price as of Jun 23, 2026 6:24 PM EDT- $89.0MMarket Cap
- -73.16%1-Year Change
- BiotechnologyIndustry
AARDVARK THERA (AARD)
$4.22-$0.02 (-0.35%)
AARD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.23 | ||
Change | +$0.15 (+3.68%) | ||
Open | $4.06 | ||
High | $4.45 | ||
Low | $4.03 | ||
Previous Close | $4.08 | ||
Volume | 112,399 | ||
30-Day Average Volume | 137,097 | ||
1-Week Change | 13.71% | ||
1-Month Change | -6.83% | ||
1-Year Change | -73.16% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 21.8M | ||
Total Assets | $98.6M | ||
Market Cap | $89.0M | ||
Enterprise Value | $26.6M | ||
Period: QTR TTM FY | |||
Revenue | -$13,000.00 | ||
Net Income | -$21.6M | ||
Free Cash Flow | -$18.9M | ||
EBIT | -$21.6M | ||
EBITDA | -$21.6M | ||
Net Working Capital | $82.0M | ||
EPS | -$0.99 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | -2,044 | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 2 | ||
Last Split Date | 07/21/2008 | ||
Earnings & Revenue